Inshad Khan

Prof. Dr. Inshad Khan


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
SSSamsher Singh
Samsher Singh
DKDr. Nitin Pal Kalia
Dr. Nitin Pal Kalia
PJPrashant Joshi
Prashant Joshi
AKAjay Kumar
Ajay Kumar
PSParduman R. Sharma
Parduman R. Sharma
IKInshad Khan
Inshad Khan
This study elucidated the role of boeravinone B, a NorA multidrug efflux pump inhibitor, in biofilm inhibition. The effects of boeravinone B plus ciprofloxacin, a NorA substrate, were evaluated in NorA-overexpressing, wild-type, and knocked-out Staphylococcus aureus (SA-1199B, SA-1199, and SA-K1758, respectively). The mechanism of action was confirmed using the ethidium bromide accumulation and efflux assay. The role of boeravinone B as a human P-glycoprotein (P-gp) inhibitor was examined in the LS-180 (colon cancer) cell line. Moreover, its role in the inhibition of biofilm formation and intracellular invasion of S. aureus in macrophages was studied. Boeravinone B reduced the minimum inhibitory concentration (MIC) of ciprofloxacin against S. aureus and its methicillin-resistant strains; the effect was stronger in SA-1199B. Furthermore, time–kill kinetics revealed that boeravinone B plus ciprofloxacin, at subinhibitory concentration (0.25 × MIC), is as equipotent as that at the MIC level. This combination also had a reduced mutation prevention concentration. Boeravinone B reduced the efflux of ethidium bromide and increased the accumulation, thus strengthening the role as a NorA inhibitor. Biofilm formation was reduced by 4–8 folds of the minimal biofilm inhibitory concentration of ciprofloxacin, effectively preventing bacterial entry into macrophages. Boeravinone B effectively inhibited P-gp with half maximal inhibitory concentration (IC50) of 64.85 µM. The study concluded that boeravinone B not only inhibits the NorA-mediated efflux of quinolones but also considerably inhibits the biofilm formation of S. aureus. Its P-gp inhibition activity demonstrates its potential as a bioavailability and bioefficacy enhancer.

31 January 2011 in Microbial Pathogenesis
Verified
Journal Article
Closed access
MKManoj Kumar
Manoj Kumar
FKFarrah G. Khan
Farrah G. Khan
SSSandeep Sharma
Sandeep Sharma
RKRajinder Kumar
Rajinder Kumar
JFJaya Faujdar
Jaya Faujdar
IKInshad Khan
Inshad Khan

19 May 2011 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
FAF. Ali
F. Ali
PSP. L. Sangwan
P. L. Sangwan
SKS. Koul
S. Koul
APA. Pandey
A. Pandey
SBS. Bani
S. Bani
IKInshad Khan
Inshad Khan

24 August 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
VARUN PRATAP SINGHVARUN PRATAP SINGH
VARUN PRATAP SINGH
Anup S PathaniaAnup S Pathania
Anup S Pathania
MKManoj Kushwaha
Manoj Kushwaha
SSSamsher Singh
Samsher Singh
VSVandana Sharma
Vandana Sharma
RVRam A. Vishwakarma
Ram A. Vishwakarma
Velutibol A (1), a new 14-residue peptaibol was isolated from the Himalayan cold habitat fungus Trichoderma velutinum. The structural characterization was carried out by 1D and 2D NMR studies, and tandem mass studies, and Marfey's method aided in determining the stereochemistry of the amino acids. The CD analysis revealed folding of the peptide in a 310-helical conformation. The intramolecular H-bonding was determined by an NMR-VT experiment. Cytotoxic evaluation was carried out against a panel of cancer cell lines. The cell cycle assay was carried out on human myeloid leukaemia (HL-60) cells and revealed the formation of apoptotic bodies and DNA damage in a dose-dependent manner. Three other peptaibols namely velutibol B (2), velutibol C (3), and velutibol D (4) were also isolated in trace amounts from the psychotropic fungus and characterized through tandem mass spectroscopy and Marfey's analysis.

16 April 2021 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
DRDiksha Raina
Diksha Raina
HTHarshita Tiwari
Harshita Tiwari
SSSmriti Sharma
Smriti Sharma
DEDeepika
Deepika
PCPraveen Kumar Chinthakindi
Praveen Kumar Chinthakindi
IKInshad Khan
Inshad Khan

12 July 2022 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
DRDiksha Raina
Diksha Raina
FKFarrah Gul Khan
Farrah Gul Khan
HTHarshita Tiwari
Harshita Tiwari
PSPayare L. Sangwan
Payare L. Sangwan
ANAmit Nargotra
Amit Nargotra
SSSaurabh Saran
Saurabh Saran